23-valent pneumococcal vaccine. Statement of the consultive committee of immunizations on behalf of the Chilean Infectious Diseases Society: February 2010

Erna Ripoll M, M. Teresa Valenzuela B, Rodrigo Vergara F, Katia Abarca V, Alma Muñoz M, Jorge Jiménez de la Jara, M. Eugenia Pinto C, Vivian Luchsinger F

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The article summarizes the scientific evidence related with protection conferred by the 23 valent polysacchardie vaccine against invasive pneumococcal disease, non bacteriemic pneumococcal pneumonia, and probable pneumococal pneumonia in the elderly. Elder patients with and without risk factors are considered. The impact of herd immunitty conferred by vaccination of children with conjugated pneumococcal vaccine in reduction of penumonia in adults is discussed. Based on this analysis, the Advisory Committee on Immunizations of the Chilean Infectious Disease Society makes recommendations on the most efficient vaccine strategy for reduction of pneumococcal pneumonia in the elderly.
Original languageAmerican English
Pages (from-to)133-137
Number of pages5
JournalRevista Chilena de Infectologia
Volume27
Issue number2
StatePublished - 1 Jan 2010
Externally publishedYes

Keywords

  • 23 valent polysaccharide pneumococcal vaccine streptococcus pneumoniae
  • Elderly people
  • Pneumococcal invasive disease
  • Pneumonia

Fingerprint Dive into the research topics of '23-valent pneumococcal vaccine. Statement of the consultive committee of immunizations on behalf of the Chilean Infectious Diseases Society: February 2010'. Together they form a unique fingerprint.

Cite this